|
|
|
1001: Upfront Salivaryglandulopexy [A Novel Option to Improve Radiation Compliance & QOL] in Patients Undergoing Radical Radiation Therapy for H & N Cancer
|
Bhalavat, Rajendra |
|
1002: Prospective Single Arm Study of Radioprotection by Amifostine in High Dose Radioiodine Therapy for Thyroid Cancer
|
Ioffe, Vladimir |
|
1003: Reproducibility of Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography(FMISO PET) in Detecting Chronic Hypoxia(CH) in Head/Neck Cancer(HNC)
|
Lee, Nancy |
|
1004: Prognostic significance of FDG PET for Head and Neck Cancer Treated with IMRT
|
Yao, Min |
|
1005: Patterns of Neck Relapse after Elective Nodal Irradiation for Sinonasal Tumors: Implications for Nodal Volume Delineation
|
Truong, Minh Tam |
|
1006: Reirradiation for Locally Recurrent Nasopharyngeal Carcinoma (NPC) Using Intensity Modulated Radiotherapy (IMRT)Clinical Outcome and Prognostic Factors
|
Han, Fei |
|
1007: Longitudinal Changes in Quality of Life and Treatment Costs in Long-term Survivors of Tumors of the Oropharynx treatedwith Brachytherapy or Surgery
|
Levendag, Peter |
|
1008: Evaluation of Larynx Dose with Extended Field IMRT for Head and Neck Cancer
|
Millender, Laura |
|
1009: Feasibility of AC Electromagnetic Localization for Radiation Therapy Head and Neck Cancer
|
Mate, Timothy |
|
1010: Should Eye Structures Be Specified During IMRT Planning?
|
Seid, Patricia |
|
1011: No Protecting Effect of Amifostine (A) on Acute Toxicity of Chemoradiation in Head and Neck Cancer
|
Catherine, Durdux |
|
1012: 18F-FDG PET in Evaluating the Response to Concurrent Chemoradiation Therapy for Nasopharyngeal Carcinoma with T4 Stage
|
Lin, Chen-Yu |
|
1013: Dose Escalation of Three-Dimensional Conformal Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma: A Prospective Randomized Study
|
Li, Jian-Cheng |
|
2205: Late Delayed Radiation Encephalopathy after Radiotherapy(RT) for Nasopharyngeal Carcinoma(NPC)
|
Yang, Yunli |
|
2206: Differentiated Thyroid Carcinoma: Analysis of Extra-thyroidal Extension and Residual Disease
|
Sia, Michael |
|
2207: First Clinical Application of MV Cone-Beam CT: Patient Positioning during Radiation Treatment
|
Gillis, Amy |
|
2208: Variations in Adverse Event Reporting In Phase III Head and Neck Trials (1990 to 2003): A Systematic Review
|
Gwede, Clement |
|
2209: Effect of DRR Resolution on Assessment of Patient Position for Head and Neck IMRT
|
Esthappan, Jacqueline |
|
2210: Impact of Radiographic Findings on Prognosis for Skin Carcinoma with Clinical Perineural Invasion
|
Galloway, Thomas |
|
2211: Measurement of IMRT Head and Neck Setup Error Using an On-board Kilovoltage Imager
|
Mechalakos, James |
|
2212: When Should We Evaluate Tumor Response for Expecting Tumor Cure in Chemoradiotherapy for Head and Neck Cancer?
|
Kawashima, Mitsuhiko |
|
2213: Prediction of Outcome by Cisplatin DNA-adduct Formation in Patients with Stage III/IV Head and Neck Squamous CellCarcinoma, Treated by Concurrent Cisplatin-Chemoradiation (RADPLAT)
|
Hoebers, Frank |
|
2214: Outcome and Prognostic Factors in Olfactory Neuroblastoma: a Multicenter Rare Cancer Network Study
|
Ozsahin, Mahmut |
|
2215: Carbon Ion Radiotherapy for Mucosal Malignant Melanoma of the Head and Neck
|
Kagawa, Kazufumi |
|
2216: Analysis of Interfractional Set-up Errors and Intrafractional Organ Motions during IMRT for Head and Neck Cancers toDefine an Appropriate PTV-margin
|
Suzuki, Minoru |
|
2217: MV Cone-Beam CT to Monitor Anatomic Changes in Patients with Head and Neck Cancers During Radiation Treatment
|
Bucci, Mary Kara |
|
2218: Concurrent Chemoradiation Followed by Interstitial Brachytherapy Boost and Neck Dissection for T4 Base of Tongue Cancer
|
Han, Peter |
|
2219: Hyperfractionated Radiation Therapy and Cisplatin for Locally Advanced Head and Neck Cancer (LAHNC): a Comparison among Two Consecutive Protocols of Treatment at a Single-Institution
|
Arias, Fernando |
|
2220: Concurrent Chemoradiation Increases Organ Preservation as well as Organ Dysfunction for Patients with Oropharynx Cancer
|
Greven, Kathryn |
|
2221: IMRT Dosimetry of the Head and Neck: a Comparison of Treatment Plans Using Linac-Based IMRT and Helical Tomotherapy
|
Molloy, Janelle |
|
2222: Evolution in H&N IMRT Practice and Early Assessment of Outcome at a Single Academic Center
|
Shah, Hiral |
|
2223: Major Salivary Gland Function: Diffusion-weighted MRI (DWI) Assessment Before, During and After Radiation Therapy
|
Studer, Gabriela |
|
2224: Use of Daily Megavoltage CT Imaging to Determine Delivered Dose Variations in Head and Neck Cancer Patients
|
Jenkins, Wayne |
|
2225: Pretreatment Anemia in Head and Neck Squamous Cells of the Head and Neck Carcinomas Treated by Chemoradiotherapy
|
Wang, Chang |
|
2226: The Study on Regulation for the Distribution of Metastatic Cervical Lymph Nodes of Nasopharyngeal Carcinoma
|
Sun, Ying |
|
2227: Analysis of Gross Target Volume (GTV) Observer Variability with FDG-PET and Contrast Enhanced CT in Head and Neck Cancer Using Finite Element Modeling
|
De Silva, Shiroma |
|
2228: Visual and Textual Evaluation of the Three Nodal Classifications for Head and Neck Cancer (Rotterdam Consensus, Richter, Martinez-Monge)
|
Hayman, L. Anne |
|
2229: Concomitant Chemoradiation Using Weekly Carboplatin/Paclitaxel With or Without Daily Subcutaneous Amifostine in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck
|
Haddad, Robert |
|
2230: Concurrent Chemoradiation Therapy with Low-Dose CDDP and UFT for Glottic Carcinomas: Evaluation Using The Sixth Edition of The UICC TNM Staging System
|
Murakami, Ryuji |
|
2231: Dose Escalation with Intensity Modulated Radiotherapy for T3-T4 Nasopharyngeal Carcinoma
|
Kwong, Dora |
|
2232: Topical Application of Amifostine for Prevention of Radiation-Induced Teeth and Gum Damage
|
Wang, Shengzi |
|
2233: Comparison of Radiotherapy (XRT), Chemoradiotherapy (CHEMORAD) and Postoperative Radiotherapy (PORT) for Stage T2 Squamous Cells Carcinomas of the Head and Neck
|
Fortin, Andre |
|
2234: Brain Necrosis in Nasopharyngeal Cancer Patients - Prospective Study with MRI
|
Chang, Joseph |
|
2235: Automated Intracranial Contouring for Brain Cancer Patients: Treatment Plan Validation
|
Niermann, Kenneth |
|
2236: Inter-observer Contouring Variations of Head-and-Neck Anatomy
|
Barker, J |
|
2237: Maturing Toxicity and Outcomes of a Phase I Trial of Concurrent, Daily Gefitinib and Radiation or Chemoradiation for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN)
|
Raben, D |
|
2238: Is Selective/Modified Radical Neck Dissection Necessary following CERT (Chemotherapy Enhanced Radiation Therapy) for Advanced Head and Neck Cancer with Persistent Neck Disease?
|
Sandhu, Ajay |
|
2239: Re-irradiation of Recurrent Head and Neck Cancers with IMRT Technique and Concurrent Chemotherapy
|
Biagioli, Matthew |
|
2240: Significant Improvement of Parotid Flow of IMRT compared to Conventional Radiotherapy in Oropharyngeal Cancer
|
Terhaard, Chris |
|
2241: Dose Escalation of Daily Carboplatin Concurrent with Accelerated Radiation by Delayed Concomitant Boost for Locally Advanced Head and Neck Cancer
|
Hu, Kenneth |
|
2242: The Significance of Thrombocytosis Prior to Radiotherapy in Patients with Nasopharyngeal Carcinoma
|
Huang, Ying |
|
2243: Multiple Dysregulated Pathways in Nasopharyngeal Carcinoma Revealed by Gene Expression Profiling
|
Liu, Fei-Fei |
|
2244: Radiotherapy for Solitary Extramedullary Plasmacytoma in the Head and Neck Region: a Dose Upper than 45 Gy on Target Volume Improves Local Control
|
tournier-rangeard, laetitia |
|
2245: Impact of Tissue Heterogeneity Corrections on Tumor and Normal Structure Dosimetry in Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiation Therapy
|
Sanfilippo, Nicholas |
|
2246: High Dose Cisplatin and Conformal Radiation for Cervical Esophageal Cancer
|
Huang, S |
|
2247: The Evaluation of Amifostine for Mucosal Protection in Advanced Loco-Regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) Treated with Concurrent Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy (RT)
|
Suntharalingam, Mohan |
|
2248: A Small Molecule Inhibitor of Methylthioadenosine Phosphorylase (MTAP) for the Treatment of Human Head and Neck Carcinoma
|
Basu, Indranil |
|
2249: Effect of the Parotid Function on the Dental Health after Radiotherapy of the Head and Neck Region
|
Rudat, Volker |
|
2250: Post-Operative Radiotherapy in the Treatment of Paranasal Sinus and Nasal Cavity and Cancer
|
Hoppe, Bradford |
|
2251: Post-Radiotherapy Neck Dissection Following Comprehensive H&N IMRT
|
Richards, Gregory |
|
2252: Contribution of PET/CT in Radiation Therapy Treatment Planning
|
Ashamalla, Hani |
|
2253: Improving CTV Target Delineation in Nasopharyngeal Carcinoma (NPC) Using a Novel Strategy Based on Three Nodal Classifications
|
Mai, Wei-Yuan |
|
2254: Accelerated Hyperfractionated Intensity Modulated Radiotherapy (AHI) for T2-3 Oropharyngeal Carcinoma: Preliminary Results from a Phase I-II Study
|
Sanguineti, Giuseppe |
|
2255: Effects of the Radio-Therapeutic Treatment of ENT Cancers on Quality of Life, the ORCO National Observatory
|
Durand-Zaleski, Isabelle |
|
2256: CyberKnife Fractionated Stereotactic Radiosurgery for the Treatment of Primary and Recurrent Head and Neck Cancer
|
Liao, Jay |
|
2257: The Prognostic Value of Hemoglobin Concentration in Postoperative Radiotherapy for Laryngeal Cancer
|
Suwinski, Rafal |
|
2258: Preliminary Results of Intensity Modulated Radiation Therapy Alone for 122 Patients with Untreated Nasopharyngeal Carcinoma
|
Zhao, Chong |
|
2259: Pattern of Failures after Intensity-Modulated Radiotherapy for Advanced Thyroid Carcinoma
|
Huang, Kim |
|
2260: Combining H&N IMRT with Weekly Cisplatin Chemotherapy: Early Toxicity and Outcome
|
Khuntia, Deepak |
|
